MEADOWVIEW PSYCHIATRIC HOSPITAL
1. Target Overview & Investment Thesis
MEADOWVIEW PSYCHIATRIC HOSPITAL is a 84-bed suburban community hospital in HUDSON, NJ with $28.3M in net patient revenue and a -16.6% operating margin. The hospital serves a payer mix of 1.8% Medicare, 0.2% Medicaid, and 98.0% commercial.
Thesis: Turnaround. Our ML models identify $2.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -16.6% to -9.2% (+736bps).
| Net Revenue HCRIS | $28.3M |
| Current EBITDA COMPUTED | $-4.7M |
| Operating Margin COMPUTED | -16.6% |
| Occupancy HCRIS | 90.0% |
| Revenue / Bed COMPUTED | $337K |
| Net-to-Gross HCRIS | 100.0% |
| Distress Probability ML | 45.8% |
2. Market Context & Competitive Position
NJ has 95 Medicare-certified hospitals with a median operating margin of -3.9%. The target's margin of -16.6% places it below the state median. Among 40 size-comparable peers (42-168 beds), the median margin is -6.3%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (42-168), prioritizing same-state peers. 40 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| MEADOWVIEW PSYCHIATRIC HOSPITA (Target) | NJ | 84 | $28.3M | -16.6% |
| HELENE FULD MEDICAL CENTER | NJ | 162 | $430.2M | -3.2% |
| SOUTHERN OCEAN MEDICAL CENTER | NJ | 147 | $233.0M | 10.5% |
| DEBORAH HEART AND LUNG CENTER | NJ | 85 | $211.9M | -5.5% |
| ST LUKES WARREN HOSPITAL | NJ | 92 | $200.8M | 28.1% |
| ST. MICHAELS MEDICAL CENTER | NJ | 147 | $198.6M | -13.6% |
| ROBERT WOOD JOHNSON HOSPITAL @ | NJ | 152 | $193.9M | -15.5% |
| NEWTON MEDICAL CENTER | NJ | 139 | $189.3M | -6.7% |
| BERGEN NEW BRIDGE MEDICAL CENT | NJ | 101 | $187.0M | -39.4% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.1M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $594K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $566K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $560K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $344K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $18K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-4.7M |
| + RCM Uplift | +$2.1M |
| Pro Forma EBITDA | $-2.6M |
| Current Margin | -16.6% |
| Pro Forma Margin | -9.2% |
| WC Released (1x) | $1.1M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-7.2M | $-10.1M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-7.2M | $-13.4M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-6.5M | $-8.9M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-6.5M | $-11.6M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-7.9M | $-18.2M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-7.9M | $-22.5M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 40 hospitals with 42-168 beds
- Same-state prioritization (n=41)
- Comp margins: P25=-35.3% / P50=-6.3% / P75=2.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.